Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-26 @ 10:58 AM
Ignite Modification Date: 2025-12-26 @ 10:58 AM
NCT ID: NCT02353806
Eligibility Criteria: Inclusion Criteria: * 18 years or older; * Pregnant female * Already taking amlodipine 5 mg for treatment of chronic hypertension in pregnancy; * Hospitalized following routine term vaginal delivery or uncomplicated cesarean delivery * Breastfeeding or breast and bottle-feeding their infant Exclusion Criteria: * Known kidney disease * Delivery complicated by chorioamnionitis, endometritis or postpartum hemorrhage * Administration of greater than 5 mg of amlodipine in 24 hour period
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Maximum Age: 50 Years
Study: NCT02353806
Study Brief:
Protocol Section: NCT02353806